Genprex
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -4,461 | -3,505 | -3,343 |
EBIT | 12,451 | ||
Net Income | -4,461 | -3,790 | -3,799 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -3,138 | -4,098 | -3,187 |
Cash | 18,049 | 7,830 | 1,103 |
Basic Shares | 316 | 42 | 34 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6 | -15 | -25 | |
EBITDA | -15,489 | -21,104 | -30,845 | -23,715 |
EBIT | -21,111 | -30,860 | -23,740 | |
Net Income | -16,228 | -21,111 | -30,860 | -23,740 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,311 | -17,149 | -24,809 | -17,778 |
Cash | 7,830 | 1,601 | 6,737 | 20,954 |
Basic Shares | 42 | 3 | 1 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$9.40 |
2026-03-31 | -$14.11 |
2025-12-31 | -$25.33 |
2025-09-30 | -$5 |